Global X Genomics & Biotechnology ETF
GNOM
GNOM
38 hedge funds and large institutions have $76.4M invested in Global X Genomics & Biotechnology ETF in 2021 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 15 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
4.53% less ownership
Funds ownership: 13.76% → 9.23% (-4.5%)
Holders
38
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$18.1M | |
| 2 | +$6M | |
| 3 | +$4.91M | |
| 4 |
T
TRUADVICE
Sarasota,
Florida
|
+$3.07M |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$1.73M |
Top Sellers
| 1 | -$17.8M | |
| 2 | -$2.19M | |
| 3 | -$509K | |
| 4 |
CFGS
Concourse Financial Group Securities
Birmingham,
Alabama
|
-$57.2K |
| 5 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$12K |